Continuing-Education
Drug Information Association has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 1760 Old Meadow Road, Suite 500, McLean, VA 22102.
As an IACET Authorized Provider, Drug Information Association offers CEUs for its programs that qualify under the ANSI/IACET Standard. Drug Information Association is authorized by IACET to offer .3 CEUs for this program. Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.
This program is part of DIA’s Certificate Program and is awarded the following:
• Regulatory Affairs Certificate Program: 2 Elective Units
For more information go to www.diahome.org/certificateprograms
Name | Credit Type | Max Credits | CEU |
#20: Japan Regulatory Environment | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#21: FDA Enforcement: Understanding the Agency's | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#22: Global Reimbursement Systems | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#23: A Device Primer: 510(k)s, PMAs, IDEs | Credit TypeCME | Max Credits3.25 | CEU0.000 |
#23: A Device Primer: 510(k)s, PMAs, IDEs | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#24: Designing, Operating, and Evaluating Patient | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
#24: Designing, Operating, and Evaluating Patient | Credit TypeCME | Max Credits3.25 | CEU0.000 |
#24: Designing, Operating, and Evaluating Patient | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#24: Designing, Operating, and Evaluating Patient | Credit TypeRN | Max Credits3.25 | CEU0.000 |
#25: Leadership: How to Organize and Lead People | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#25: Leadership: How to Organize and Lead People | Credit TypePMI | Max Credits3.25 | CEU0.000 |
#30: Analysis of Safety Data from Clinical Trials | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
#30: Analysis of Safety Data from Clinical Trials | Credit TypeCME | Max Credits3.25 | CEU0.000 |
#30: Analysis of Safety Data from Clinical Trials | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#31: Highlights of the New PV Legislation in EU | Credit TypeCME | Max Credits3.25 | CEU0.000 |
#31: Highlights of the New PV Legislation in EU | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#32: Understanding Translational Medicine | Credit TypeCME | Max Credits3.25 | CEU0.000 |
#32: Understanding Translational Medicine | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#33: Understanding CER/HTA in Biopharma | Credit TypeACPE | Max Credits3.25 | CEU0.325 |
#33: Understanding CER/HTA in Biopharma | Credit TypeCME | Max Credits3.25 | CEU0.000 |
#33: Understanding CER/HTA in Biopharma | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#33: Understanding CER/HTA in Biopharma | Credit TypeRN | Max Credits3.25 | CEU0.000 |
#34: Fourteen Steps from Research to Development | Credit TypeCME | Max Credits3.25 | CEU0.000 |
#34: Fourteen Steps from Research to Development | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#35: Successful Drug Development: Best Practices | Credit TypeIACET | Max Credits3.25 | CEU0.300 |
#40: Investigative Site Boot Camp | Credit TypeCME | Max Credits4.75 | CEU0.000 |
#40: Investigative Site Boot Camp | Credit TypeIACET | Max Credits4.75 | CEU0.500 |
#41: The DIA - HBA Skill Building Series | Credit TypeIACET | Max Credits4.75 | CEU0.500 |
#50: Understanding and Navigating the Reg Sys in C | Credit TypeIACET | Max Credits6.50 | CEU0.700 |
#51: Quality Oversight of CROs-Clinical Vendors | Credit TypeIACET | Max Credits6.50 | CEU0.700 |
#52: Regulatory Affairs for Biologics | Credit TypeIACET | Max Credits6.50 | CEU0.700 |
#53: Clinical Statistics for Nonstatisticians | Credit TypeACPE | Max Credits6.50 | CEU0.650 |
#53: Clinical Statistics for Nonstatisticians | Credit TypeCME | Max Credits6.50 | CEU0.000 |
#53: Clinical Statistics for Nonstatisticians | Credit TypeIACET | Max Credits6.50 | CEU0.700 |
#54: Art of Writing a Clinical Overview | Credit TypeIACET | Max Credits6.50 | CEU0.700 |
#55: Overview of Drug Development | Credit TypeIACET | Max Credits6.50 | CEU0.700 |
#55: Overview of Drug Development | Credit TypePMI | Max Credits6.50 | CEU0.000 |
#56: Risk Communications | Credit TypeACPE | Max Credits6.50 | CEU0.650 |
#56: Risk Communications | Credit TypeCME | Max Credits6.50 | CEU0.000 |
#56: Risk Communications | Credit TypeIACET | Max Credits6.50 | CEU0.700 |
#56: Risk Communications | Credit TypeRN | Max Credits6.50 | CEU0.000 |
#57: Preparing for a US FDA Advisory Committee Me | Credit TypeIACET | Max Credits5.25 | CEU0.500 |
DIA 2013 49th Annual Meeting | Credit TypeACPE | Max Credits18.00 | CEU1.800 |
DIA 2013 49th Annual Meeting | Credit TypeCME | Max Credits18.00 | CEU0.000 |
DIA 2013 49th Annual Meeting | Credit TypeIACET | Max Credits24.00 | CEU2.400 |
DIA 2013 49th Annual Meeting | Credit TypePMI | Max Credits12.00 | CEU0.000 |
DIA 2013 49th Annual Meeting | Credit TypeRN | Max Credits18.00 | CEU0.000 |
Statement of Credit:
If you would like to receive a statement of credit, you must attend the activity, scan your badge at the registration desk, and complete the on-line credit request process through My Transcript at www.diahome.org. Participants will be able to download a statement of credit upon successful submission of the credit request. My Transcript will be available for credit requests on July 2, 2013.Have an account?